Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| ESCA | rs112649976 | chr3:125641926 | C/T | 7.58E-5 | 175 | 13.03 | 18.6 | 3.47 | KM Plot |
| ESCA | rs112840743 | chr9:90921861 | G/A | 5.56E-5 | 182 | 13.37 | 13.1 | 3.93 | KM Plot |
| ESCA | rs11295775 | chr10:77435465 | CT/C | 7.62E-5 | 178 | 3.73 | 12.87 | 13.35 | KM Plot |
| ESCA | rs113026312 | chr7:111256664 | C/A | 0 | 183 | 13.35 | 14.5 | 0.8 | KM Plot |
| ESCA | rs113260909 | chr15:65609992 | G/A | 8.08E-5 | 182 | 12.85 | 17.48 | 4.08 | KM Plot |
| ESCA | rs113294017 | chr1:3204319 | T/C | 3.32E-9 | 177 | 12.87 | 17.87 | 3.22 | KM Plot |
| ESCA | rs113399762 | chr11:118389698 | T/C | 4.15E-10 | 182 | 13.35 | 15.57 | 1.4 | KM Plot |
| ESCA | rs113572413 | chr15:81887859 | G/GAT | 8.26E-8 | 183 | 13.1 | 14.65 | 3.7 | KM Plot |
| ESCA | rs113619399 | chr1:3698815 | CTT/C | 1.75E-12 | 183 | 13.03 | 16.4 | 2.27 | KM Plot |
| ESCA | rs113656095 | chr9:90916811 | C/T | 5.56E-5 | 182 | 13.37 | 13.1 | 3.93 | KM Plot |
| ESCA | rs113734034 | chr7:111259599 | G/T | 0 | 183 | 13.35 | 14.5 | 0.8 | KM Plot |
| ESCA | rs113788683 | chr8:120879772 | CATTT/C | 7.47E-6 | 183 | 12.87 | 18.58 | 3.6 | KM Plot |
| ESCA | rs113823186 | chr3:184198310 | G/A | 5.96E-5 | 179 | 13.37 | 13.97 | 5.07 | KM Plot |
| ESCA | rs113961818 | chr12:110423670 | AAC/A | 2.74E-5 | 178 | 13.35 | 12.87 | 3.2 | KM Plot |
| ESCA | rs11409002 | chr8:120873147 | C/CT | 1.24E-14 | 177 | 13 | 18.58 | 2.02 | KM Plot |